- Home
- JZXN vs AWH Comparison
JZXN vs AWH Comparison
Compare JZXN & AWH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZXN
- AWH
- Stock Information
- Founded
- JZXN 2017
- AWH 1993
- Country
- JZXN China
- AWH United States
- Employees
- JZXN N/A
- AWH N/A
- Industry
- JZXN Retail-Auto Dealers and Gas Stations
- AWH Medical/Dental Instruments
- Sector
- JZXN Consumer Discretionary
- AWH Health Care
- Exchange
- JZXN Nasdaq
- AWH Nasdaq
- Market Cap
- JZXN 15.3M
- AWH 13.5M
- IPO Year
- JZXN 2021
- AWH N/A
- Fundamental
- Price
- JZXN $1.31
- AWH $0.76
- Analyst Decision
- JZXN
- AWH Buy
- Analyst Count
- JZXN 0
- AWH 2
- Target Price
- JZXN N/A
- AWH $4.40
- AVG Volume (30 Days)
- JZXN 27.3K
- AWH 62.1K
- Earning Date
- JZXN 10-22-2024
- AWH 11-11-2024
- Dividend Yield
- JZXN N/A
- AWH N/A
- EPS Growth
- JZXN N/A
- AWH N/A
- EPS
- JZXN N/A
- AWH N/A
- Revenue
- JZXN $7,597,423.00
- AWH $8,923,000.00
- Revenue This Year
- JZXN N/A
- AWH $15.59
- Revenue Next Year
- JZXN N/A
- AWH $108.47
- P/E Ratio
- JZXN N/A
- AWH N/A
- Revenue Growth
- JZXN 81.94
- AWH N/A
- 52 Week Low
- JZXN $1.00
- AWH $0.74
- 52 Week High
- JZXN $67.60
- AWH $6.01
- Technical
- Relative Strength Index (RSI)
- JZXN 39.30
- AWH 36.80
- Support Level
- JZXN $1.36
- AWH $0.76
- Resistance Level
- JZXN $1.76
- AWH $0.89
- Average True Range (ATR)
- JZXN 0.17
- AWH 0.06
- MACD
- JZXN -0.01
- AWH 0.01
- Stochastic Oscillator
- JZXN 4.84
- AWH 18.40
About JZXN Jiuzi Holdings Inc.
Jiuzi Holdings Inc operates as a franchise under the brand name Jiuzi. It sells new energy vehicles in third-fourth tier cities in China. The firm also sells plug-in electric vehicles on demand from vehicle buyers. Its business segments are sales of NEVs and Franchisees services. The company generates a majority of its revenue from the NEVs segment. Geographically, the firm operates in China.
About AWH Aspira Women's Health Inc.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.